These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9566501)

  • 1. Cognitive changes in mice following moderate MPTP exposure.
    Tanila H; Björklund M; Riekkinen P
    Brain Res Bull; 1998 Apr; 45(6):577-82. PubMed ID: 9566501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):167-72. PubMed ID: 3764080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of pros-methylimidazoleacetic acid: correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated mice.
    Prell GD; Khandelwal JK; Burns RS; Blandina P; Morrishow AM; Green JP
    J Neural Transm Park Dis Dement Sect; 1991; 3(2):109-25. PubMed ID: 1910485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of striatal dopamine turnover by stress in MPTP-treated mice.
    Urakami K; Masaki N; Shimoda K; Nishikawa S; Takahashi K
    Clin Neuropharmacol; 1988 Aug; 11(4):360-8. PubMed ID: 3264755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
    Hofele K; Sedelis M; Auburger GW; Morgan S; Huston JP; Schwarting RK
    Exp Neurol; 2001 Mar; 168(1):116-22. PubMed ID: 11170726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice.
    Khan HA
    Neurochem Int; 2010 Nov; 57(5):489-91. PubMed ID: 20619308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?
    Russ H; Mihatsch W; Gerlach M; Riederer P; Przuntek H
    Neurosci Lett; 1991 Feb; 123(1):115-8. PubMed ID: 1712088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
    Callier S; Morissette M; Grandbois M; Di Paolo T
    Synapse; 2000 Sep; 37(4):245-51. PubMed ID: 10891861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors.
    Fuller RW; Hemrick-Luecke SK; Robertson DW
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):57-65. PubMed ID: 2417293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
    Schlüter OM; Fornai F; Alessandrí MG; Takamori S; Geppert M; Jahn R; Südhof TC
    Neuroscience; 2003; 118(4):985-1002. PubMed ID: 12732244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice.
    Obuchowicz E; Antkiewicz-Michaluk L; Romańska I; Herman ZS
    J Neural Transm (Vienna); 2003 Dec; 110(12):1375-91. PubMed ID: 14666410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of manganese administration for striatal dopamine and motor behavior in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed C57BL/6 mice.
    Dodd CA; Bloomquist JR; Klein BG
    Hum Exp Toxicol; 2013 Aug; 32(8):865-80. PubMed ID: 23263854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
    Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 4-(4-methoxy-1,2,5-thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydropyridine , an analog of MPTP, on mouse heart norepinephrine and brain catecholamines.
    Hemrick-Luecke SK; Mitch CH; Quimby SJ; Fuller RW
    Neurochem Int; 1993 Nov; 23(5):467-70. PubMed ID: 8251928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice.
    Fredriksson A; Fredriksson M; Eriksson P
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):258-64. PubMed ID: 8212007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity.
    Spooren WP; Vassout A; Waldmeier P; Gentsch C
    Eur J Pharmacol; 1998 Jul; 353(1):1-4. PubMed ID: 9721033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.